Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions

Oscar R. Rosales, Brian Eades, Abid R. Assali

Research output: Contribution to journalReview articlepeer-review

Abstract

Adenosine is an endogenous nucleoside available for the diagnosis and treatment of various cardiovascular conditions. It may be given for pharmacologic stress tests as well as administered directly into the coronary arteries during cardiac catheterization. The latter treatment may be utilized to measure fractional flow reserve in addition to treating the no-reflow phenomenon. Adenosine has also been shown to improve the clinical outcome of thrombolytics given in the setting of acute myocardial infarction. Adenosine is a useful agent for evaluation and treatment of the cardiovascular system.

Original languageEnglish
Pages (from-to)358-363
Number of pages6
JournalCatheterization and Cardiovascular Interventions
Volume62
Issue number3
DOIs
StatePublished - Jul 2004
Externally publishedYes

Keywords

  • Acute myocardial infarction
  • Adenosine
  • AMI
  • AMISTAD trail
  • No-reflow phenomenon
  • Noninvasive pharmacologic stress

Fingerprint

Dive into the research topics of 'Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions'. Together they form a unique fingerprint.

Cite this